Cargando…
Pathologic Response After Weekly Paclitaxel versus Docetaxel in Operable Breast Cancer
INTRODUCTION: Weekly paclitaxel (Ptx) and q3w docetaxel (Dtx) are equivalent in adjuvant breast cancer treatment. Weekly Ptx is better tolerated than q3w Dtx and became the first choice in daily practice, even preoperatively. METHODS: To compare the efficacy and safety of the two regimens, a retrosp...
Autores principales: | Bacinschi, Xenia Elena, Anghel, Rodica Maricela, Toma, Paula Iuliana, Safta, Inga, Ilie, Alis, Ilie, Silvia Mihaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051895/ https://www.ncbi.nlm.nih.gov/pubmed/32161494 http://dx.doi.org/10.2147/CMAR.S234527 |
Ejemplares similares
-
Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis
por: Ilie, Silvia Mihaela, et al.
Publicado: (2018) -
Biomolecular Factors Represented by Bcl-2, p53, and Tumor-Infiltrating Lymphocytes Predict Response for Adjuvant Anthracycline Chemotherapy in Patients with Early Triple-Negative Breast Cancer
por: Bacinschi, Xenia Elena, et al.
Publicado: (2020) -
Assessment of Immune Status in Dynamics for Patients with Cancer Undergoing Immunotherapy
por: Xenia Elena, Bacinschi, et al.
Publicado: (2021) -
Quantitative Analysis of SPECT-CT Data in Metastatic Breast Cancer Patients—The Clinical Significance
por: Gherghe, Mirela, et al.
Publicado: (2022) -
A Real-World Study to Compare the Safety and Efficacy of Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir, with or without Ribavirin, in 587 Patients with Chronic Hepatitis C at the Fundeni Clinical Institute, Bucharest, Romania
por: Bacinschi, Xenia, et al.
Publicado: (2022)